2.4. Costimulation Blockade
This protocol is extracted from research article:
Prevention of CD8 T Cell Deletion during Chronic Viral Infection
Viruses, Jun 22, 2021; DOI: 10.3390/v13071189

Mice received 250 µg CTLA4-Ig (Sigma, non-cytolytic) i.p. once daily or every other day on days 4–8 after infection. Control mice were treated in parallel with 250 µg matched mouse IgG2a isotype control antibody (BD Pharmingen, La Jolla, CA, USA).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.